MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JOHNSON, D. A.
Right arrow Articles by LOH, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JOHNSON, D. A.
Right arrow Articles by LOH, H.

Molecular Pharmacology, Vol 17, 52-55, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Adaptation to Ethanol-Induced Fluidization of Brain Lipid Bilayers: Cross-Tolerance and Reversibility

DAVID A. JOHNSON 1, NANCY M. LEE 1, ROGER COOKE 1, and HORACE LOH 1

1 Langley Porter Neuropsychiatric Institute and Departments of Psychiatry, Biochemistry/Biophysics and Pharmacology, University of California, San Francisco, San Francisco, California 94143

Apparent tolerance to the ability of ethanol to increase membrane lipid thermal motions or membrane fluidity of artificial membranes formed from the lipid extracts of tolerant mice synaptosomal membranes has recently been observed by us. We attempted to determine whether this apparent tolerance was correlated with tolerance to the anesthetic actions of ethanol. We, consequently, measured the ability of ethanol to "fluidize" artificial membranes prepared from the membrane lipid extracts from pentobarbital, from morphine, and from pre- and postwithdrawal ethanol-tolerant mice. Membrane fluidity was assessed by measuring the fluorescence polarization of 1,6-diphenyl-l,3,5-hexatriene incorporated into the membranes. We observed that ethanol showed cross-tolerance with pentobarbital but not with morphine. Also, after withdrawal the effects of chronic ethanol treatment were reversible. The data suggest that the change in brain membrane lipid composition responsible for the apparent tolerance to the membrane "fluidizing" effects of ethanol is related to tolerance to the anesthetic actions of ethanol.

Note:
ACKNOWLEDGMENT We would like to acknowledge the editorial and typing assistance of Kaye Welch.

Submitted on May 27, 1979
Accepted on August 28, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics